Serenity Pharmaceuticals
Brooklyn, US · Delaware LLC
Find your way into Serenity Pharmaceuticals
Sign up to see every warm intro you have to Serenity Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Serenity Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SH
Samuel HerschkowitzChief Executive Officer2006–2022Samuel Herschkowitz holds a leadership role in Serenity Pharmaceuticals and has served in board and advisory positions across biotechnology and health care companies.
Board
AK
Alain KodsiBoard director
SE
Steven EtkindBoard director
Reported raises · per SEC filings
Form D private placements$7.9M disclosed across 1 round · 2016
▶$7.9MraisedJul 2016 · 20 investors · PharmaceuticalsRule 506(b)
▶$7.9MraisedJul 2016 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alain KodsiDirector
- Samuel HerschkowitzExecutive Officer, Director
- Steven EtkindDirector
- Offering amount
- $10M
- Amount sold
- $7.9M
- Minimum investment
- $25K
- First sale
- Jun 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Serenity Pharmaceuticals raised?
- Serenity Pharmaceuticals has disclosed $7.9M raised across 1 round.
- Where is Serenity Pharmaceuticals headquartered?
- Serenity Pharmaceuticals is headquartered in Brooklyn, US.